ADVERTISEMENTs
.png)
Sakthivel Sadayappan to lead Dept of Cellular And Molecular Medicine at UArizona
Sadayappan also assumes the role of associate director of basic science at the Sarver Heart Center.
Sakthivel Sadayappan / Image- University of Arizona College of Medicine – Tucson
The University of Arizona College of Medicine – Tucson has appointed Sakthivel Sadayappan, as the new head of its Department of Cellular and Molecular Medicine.
Sadayappan joins the university from the University of Cincinnati College of Medicine, where he led significant research funded by the National Institutes of Health and the American Heart Association.
His career also includes roles at the University of Cincinnati, Loyola University in Chicago, and the Max Planck Institute for Heart and Lung Research in Germany.
With over 170 published scientific papers and three patents, Sadayappan’s research aims to uncover therapies for genetically induced heart failure and conditions such as distal arthrogryposis and lethal congenital contracture syndrome.
He has been honored as educator of the year and has mentored over 100 students and postdoctoral fellows.
“Dr. Sadayappan is a prolific and accomplished researcher focused on improving cardiac health,” said Michael M.I. Abecassis, dean of the College of Medicine – Tucson. “We’re very pleased about his arrival and the promise his work brings to the college.”
Commenting on the role, Sadayappan said, “The University of Arizona and particularly this department, cellular and molecular medicine, is one of the best in the world. We call it the mecca for myofilament research.”
Sadayappan earned his PhD in Biochemistry from Madurai Kamaraj University in India, where he focused on molecular aspects of cardiac hypertrophy. He also holds an MBA from the University of Cincinnati Carl H. Lindner College of Business and completed a Certificate Course on Preparing for Future Faculty at the University of Cincinnati.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpg)
.jpg)
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login